Given the role of DNMTs in inhibiting tumor suppressors in ALK+ ALCL such as miRNA, they are also potential therapeutic co-targets with ALK in crizotinib resistant ALK(+) ALCL cells as previously shown [42,44]. Here, ALK is linked to anaplastic large cell lymphoma.